tiprankstipranks
Trending News
More News >
Immucell Corp. (ICCC)
NASDAQ:ICCC
US Market

Immucell (ICCC) Financial Statements

Compare
73 Followers

Immucell Financial Overview

Immucell's market cap is currently $48.15M. The company's EPS TTM is $-0.28; its P/E ratio is ―; Immucell is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 26.49M$ 17.47M$ 18.57M$ 19.24M$ 15.34M
Gross Profit$ 7.94M$ 4.40M$ 7.65M$ 8.66M$ 6.86M
Operating Income$ -1.64M$ -5.75M$ -2.30M$ -2.20M$ -1.38M
EBITDA$ 1.04M$ -2.50M$ 349.99K$ 2.72M$ 1.65M
Net Income$ -2.16M$ -5.77M$ -2.49M$ -78.00K$ -1.02M
Balance Sheet
Cash & Short-Term Investments$ 3.81M$ 978.74K$ 5.79M$ 10.19M$ 7.95M
Total Assets$ 0.00$ 43.81M$ 44.86M$ 44.47M$ 40.35M
Total Debt$ 0.00$ 16.69M$ 12.48M$ 10.27M$ 10.73M
Net Debt$ 0.00$ 15.71M$ 6.69M$ 89.03K$ 2.79M
Total Liabilities$ -26.41M$ 18.82M$ 14.48M$ 11.89M$ 12.08M
Stockholders' Equity$ 26.41M$ 24.99M$ 30.38M$ 32.58M$ 28.27M
Cash Flow
Free Cash Flow$ 0.00$ -6.57M$ -5.52M$ -1.65M$ -2.76M
Operating Cash Flow$ 0.00$ -4.67M$ -1.54M$ 954.17K$ 1.32M
Investing Cash Flow$ 0.00$ -1.89M$ -3.96M$ -1.60M$ -2.57M
Financing Cash Flow$ 0.00$ 1.75M$ 1.11M$ 3.88M$ 1.91M
Currency in USD

Immucell Earnings and Revenue History

Immucell Debt to Assets

Immucell Cash Flow

Immucell Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis